Sampurno, F;
Zheng, J;
Di Stefano, L;
Millar, JL;
Foster, C;
Fuedea, F;
Higano, C;
... Evans, S; + view all
(2018)
Quality Indicators for Global Benchmarking of Localized Prostate Cancer Management.
The Journal of Urology
, 200
(2)
pp. 319-326.
10.1016/j.juro.2018.02.071.
Preview |
Text
1-s2.0-S0022534718393777-main.pdf - Accepted Version Download (1MB) | Preview |
Abstract
PURPOSE: To develop a core set of clinical indicators that enables international benchmarking of localised prostate cancer management using data available in the TrueNTH Global Registry. MATERIALS AND METHODS: An international expert panel completed an online survey and participated in a face-to-face meeting. Participants included urologists (n=3), radiation oncologists (n=3), psychologists (n=2), medical oncologist (n=1), nurse (n=1) and an epidemiologist (n=1) with prostate cancer expertise from seven countries. Current guidelines on prostate cancer treatment and potential quality indicators were identified from a literature review. These potential indicators were refined and developed through a modified Delphi process, during which each panellist independently and repeatedly rated each indicator based on its importance (satisfying the indicator demonstrates a provision of high-quality care) and feasibility (likelihood that data being used to construct the indicator could be collected at a population level). The main outcome measure was items with panel agreement (disagreement index<1), median importance ≥8.5 and median feasibility ≥9. RESULTS AND CONCLUSION: s: Thirty-three indicators received endorsement from the expert panel. These 33 prostate cancer quality indicators assess care relating to diagnosis (n=7), primary treatment (n=7), salvage treatment (n=1) and health outcomes (n=18). In summary, we have developed a set of quality indicators for measuring prostate cancer care from numerous international evidence-based clinical guidelines. These indicators will be pilot tested in the TrueNTH Global Registry. Reports comparing indicator performance will subsequently be distributed to participating sites, with the purpose of improving the consistency and quality of prostate cancer management on a global basis.
Archive Staff Only
 |
View Item |
